Fragrance avoidance
No fragrance-linked caution surfaced in the current profile.
This ingredient does not currently read as a fragrance-linked driver in the published evidence and hazard profile.
Route: INTRAVENOUS; Dosage form: INJECTION; Potency: 1.4 mg
Concern score
The concern value reflects this ingredient's chemical identity — its hazard profile from the published classifications and regulatory status below — not the safety of a product it appears in. A score near 40 is the baseline for ingredients with no specific signal (water scores 40 by design), so a mid-range value is not a safety verdict.
Concern score 5/100 (low) · high confidence.
Context-specific fit derived from published classifications and the current ingredient evidence profile.
Fragrance avoidance
No fragrance-linked caution surfaced in the current profile.
This ingredient does not currently read as a fragrance-linked driver in the published evidence and hazard profile.
The published evidence profile currently shaping this ingredient record.
Primary documents currently linked to this ingredient record.
Structured claim signals pulled from linked ingredient research.
Published jurisdiction-level classifications and regulatory designations for this ingredient.
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION; Potency: 1.4 mg
US
FDA
Route: OPHTHALMIC; Dosage form: SOLUTION; Potency: 3 %w/w
US
FDA
Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 250 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, COATED, EXTENDED RELEASE; Potency: NA
US
FDA
Route: ORAL; Dosage form: CAPSULE, DELAYED RELEASE; Maximum daily exposure: 365 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, EXTENDED RELEASE; Potency: 25.1 mg
US
FDA
Route: ORAL; Dosage form: GRANULE; Maximum daily exposure: 238 mg
US
FDA
Route: ORAL; Dosage form: GRANULE, FOR SOLUTION; Potency: 36.3 mg/120ml
US
FDA
Route: ORAL; Dosage form: GRANULE, FOR SUSPENSION; Maximum daily exposure: 810 mg
US
FDA
Route: ORAL; Dosage form: PELLET; Maximum daily exposure: 28 mg
US
FDA
Route: ORAL; Dosage form: SUSPENSION; Maximum daily exposure: 114 mg
US
FDA
Route: ORAL; Dosage form: SUSPENSION, EXTENDED RELEASE; Potency: 186.8 mg
US
FDA
Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 2352 mg
US
FDA
Route: ORAL; Dosage form: TABLET, CHEWABLE; Maximum daily exposure: 300 mg
US
FDA
Route: ORAL; Dosage form: TABLET, CHEWABLE, EXTENDED RELEASE; Maximum daily exposure: 90 mg
US
FDA
Route: ORAL; Dosage form: TABLET, COATED; Maximum daily exposure: 208 mg
US
FDA
Route: ORAL; Dosage form: TABLET, DELAYED RELEASE; Maximum daily exposure: 336 mg
US
FDA
Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 624 mg
US
FDA
Route: ORAL; Dosage form: TABLET, FILM COATED; Maximum daily exposure: 787 mg
US
FDA
Route: ORAL; Dosage form: TABLET, FILM COATED, EXTENDED RELEASE; Maximum daily exposure: 24 mg
US
FDA
Route: ORAL; Dosage form: TABLET, FOR SUSPENSION; Maximum daily exposure: 1733 mg
US
FDA
Route: ORAL; Dosage form: TABLET, ORALLY DISINTEGRATING; Maximum daily exposure: 1260 mg
US
FDA
Route: ORAL; Dosage form: TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE; Maximum daily exposure: 660 mg
US
FDA
Route: SUBCUTANEOUS; Dosage form: PELLET; Potency: 2 mg
US
FDA
Route: SUBLINGUAL; Dosage form: TABLET; Maximum daily exposure: 60 mg
US
FDA
Route: TOPICAL; Dosage form: EMULSION; Potency: 1 %w/w
US
FDA
Route: TOPICAL; Dosage form: LOTION; Potency: 0.5 %w/w
US
FDA
Route: TRANSDERMAL; Dosage form: FILM; Maximum daily exposure: 4 mg
US
FDA
Route: TRANSDERMAL; Dosage form: FILM, EXTENDED RELEASE; Maximum daily exposure: 60 mg
US
FDA
Route: TRANSDERMAL; Dosage form: SYSTEM; Maximum daily exposure: 286 mg
US
FDA
Route: VAGINAL; Dosage form: AEROSOL, FOAM; Potency: 1 %w/w
US
FDA
Route: VAGINAL; Dosage form: SUPPOSITORY; Potency: 116.1 mg
US
FDA
openFDA substance registry classifies this ingredient as mixture.